Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells

Coll, Teresa, Álvarez-Guardia, David, Barroso, Emma, Gómez-Foix, Anna Maria, Palomer, Xavier, Laguna, Juan C., Vázquez-Carrera, Manuel · 2010 · Endocrinology

Abstract

Elevated plasma free fatty acids cause insulin resistance in skeletal muscle through the activation of a chronic inflammatory process. This process involves nuclear factor (NF)-κB activation as a result of diacylglycerol (DAG) accumulation and subsequent protein kinase Cθ (PKCθ) phosphorylation. At present, it is unknown whether peroxisome proliferator-activated receptor-δ (PPARδ) activation prevents fatty acid-induced inflammation and insulin resistance in skeletal muscle cells. In C2C12 skeletal muscle cells, the PPARδ agonist GW501516 prevented phosphorylation of insulin receptor substrate-1 at Ser307 and the inhibition of insulin-stimulated Akt phosphorylation caused by exposure to the saturated fatty acid palmitate. This latter effect was reversed by the PPARδ antagonist GSK0660. Treatment with the PPARδ agonist enhanced the expression of two well known PPARδ target genes involved in fatty acid oxidation, carnitine palmitoyltransferase-1 and pyruvate dehydrogenase kinase 4 and increased the phosphorylation of AMP-activated protein kinase, preventing the reduction in fatty acid oxidation caused by palmitate exposure. In agreement with these changes, GW501516 treatment reversed the increase in DAG and PKCθ activation caused by palmitate. These effects were abolished in the presence of the carnitine palmitoyltransferase-1 inhibitor etomoxir, thereby indicating that increased fatty acid oxidation was involved in the changes observed. Consistent with these findings, PPARδ activation by GW501516 blocked palmitate-induced NF-κB DNA-binding activity. Likewise, drug treatment inhibited the increase in IL-6 expression caused by palmitate in C2C12 and human skeletal muscle cells as well as the protein secretion of this cytokine. These findings indicate that PPARδ attenuates fatty acid-induced NF-κB activation and the subsequent development of insulin resistance in skeletal muscle cells by reducing DAG accumulation. Our results point to PPARδ activation as a pharmacological target to prevent insulin resistance.

Overview

Integrity signals

Registry

Crossref · 10.1210/en.2009-1211

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Cited by

See all 91

Metadata

Authors
Coll, T., Álvarez-Guardia, D., Barroso, E., Gómez-Foix, A. M., Palomer, X., Laguna, J. C., & Vázquez-Carrera, M.
Affiliations
  • Instituto de Salud Carlos III (ES)
  • Pharmacology Unit (T.C., D.A.-G., E.B., X.P., J.C.L., M.V.-C.), Instituto de Salud Carlos III, E-08028 Barcelona, Spain
  • Department of Pharmacology and Therapeutic Chemistry, Faculty of Pharmacy, and Department of Biochemistry and Molecular Biology (A.M.G.-F.), Faculty of Biology, University of Barcelona, Institut de Biomedicina de la Universidad de Barcelona and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, E-08028 Barcelona, Spain
Venue
Endocrinology
Published
2010-04-01
Volume
151
Issue
4
Pages
1560-1569
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2118225670
Cited by
90
References
52
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2019: 5 · 2018: 5 · 2017: 3 · 2016: 11 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 16
FWCI
5.34
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Commission
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Universitat de Barcelona
  • European Regional Development Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
PPARδ, GW501516, insulin resistance, skeletal muscle, NF-κB activation, free fatty acids, palmitate, diacylglycerol, carnitine palmitoyltransferase 1, fatty acid oxidation, AMPK, interleukin-6, inflammation, Akt phosphorylation, IRS-1
MeSH terms
Analysis of Variance, Animals, Carnitine O-Palmitoyltransferase, Cell Line, Cell Nucleus, Epoxy Compounds, Fatty Acids, Humans, Insulin Resistance, Protein Kinases, RNA, Messenger, Sulfones, Thiazoles, Thiophenes, Blotting, Western, Interleukin-6, NF-kappa B, Muscle, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, PPAR delta, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells. https://app.cochat.ai/papers/10.1210/en.2009-1211
The paper
Coll, T., Álvarez-Guardia, D., Barroso, E., Gómez-Foix, A. M., Palomer, X., Laguna, J. C., & Vázquez-Carrera, M. (2010). Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells. Endocrinology. https://doi.org/10.1210/en.2009-1211

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.